Personalized Medicine

The use of disease biomarkers and genetic profiling are becoming an increasingly critical component of drug development and personalized medicine. While targeted agents directed at unique genetic features improve drug efficacy and reduce toxicity, new paradigms in drug development also demand increased clinical evidence for patient recruitment in clinical studies. To translate personalized medicine into clinical realities, biomarker-defined populations are needed.

CliniWorks aggregates clinical, phenotypic and genetic patient-information into a single searchable repository, for the rapid identification of patients, most likely to respond to targeted therapies.